The US president’s latest tariff move will see the US impose 100% levies on imports of branded or patented pharmaceutical goods from October 1. What could it mean for global trade?
The news came in much the same way as previous tariff bombshells from the US president had suddenly, via social media, and with much left unclear. In a post on his social media site late on Thursday… [+6058 chars]
Read more: https://www.dw.com/en/trump-tariffs-who-stands-to-lose-most-from-new-us-pharma-duties/a-74143945
Source: DW (English)
